Figure 2
From: Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation
Demonstration of radiographic response to ipilimumab; CT scans performed prior to and 12 weeks after initiation of therapy demonstrate regression of lung and liver metastases (arrows).